Maranhão, Raul Cavalcante 
; Leite, Antonio Carlos de Arruda
Source: Current Pharmaceutical Design. Unidade: FCF
Subjects: INFLAMAÇÃO, ARTERIOSCLEROSE, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARANHÃO, Raul Cavalcante e LEITE, Antonio Carlos de Arruda. Development of anti-atherosclerosis therapy based on the inflammatory and proliferative aspects of the disease. Current Pharmaceutical Design, v. 21, n. 9, p. 1196-1204, 2015Tradução . . Disponível em: https://doi.org/10.2174/1381612820666141013150714. Acesso em: 27 ago. 2024.APA
Maranhão, R. C., & Leite, A. C. de A. (2015). Development of anti-atherosclerosis therapy based on the inflammatory and proliferative aspects of the disease. Current Pharmaceutical Design, 21( 9), 1196-1204. doi:10.2174/1381612820666141013150714NLM
Maranhão RC, Leite AC de A. Development of anti-atherosclerosis therapy based on the inflammatory and proliferative aspects of the disease [Internet]. Current Pharmaceutical Design. 2015 ; 21( 9): 1196-1204.[citado 2024 ago. 27 ] Available from: https://doi.org/10.2174/1381612820666141013150714Vancouver
Maranhão RC, Leite AC de A. Development of anti-atherosclerosis therapy based on the inflammatory and proliferative aspects of the disease [Internet]. Current Pharmaceutical Design. 2015 ; 21( 9): 1196-1204.[citado 2024 ago. 27 ] Available from: https://doi.org/10.2174/1381612820666141013150714
